Yi Zeng holds a bachelor’s degree in pharmacy from the Wuhan University of Engineering and an MSc in molecular biology from Jinzhou Medical University and the Chinese Academy of Sciences. He has researched brain vascular diseases, stem cell biology, and synthetic biology at institutions including GTIIT and the Technion. Currently at HKUMed, Yi studies stem cell-derived human primordial germ cells, myotonic dystrophy type 1, and infertility using CRISPR and patient-derived iEPSCs. He has published four first-author papers in journals such as Nature Communications and Stem Cell Research & Therapy. His research interests lie in genome editing and regenerative medicine.